Patents Assigned to Arizona Board of Regents, acting on hehalf of The University of Arizona
  • Wortmannin Analogs and Methods of Using Same in Combination with Chemotherapeutic Agents
    Publication number: 20090087441
    Abstract: Novel wortmannin analogs and their use in inhibiting PI-3-kinase activity in mammals and the treatment or prevention of cancer and tumor formation in a subject are described herein. Preferably, the wortmannin analogs may be administered with other chemotherapeutic agents in the treatment of cancer.
    Type: Application
    Filed: September 23, 2008
    Publication date: April 2, 2009
    Applicants: Prolx Pharmaceuticals Corp., Arizona Board of Regents, acting on hehalf of The University of Arizona, The University of Pittsburgh
    Inventors: Lynn Kirkpatrick, Garth Powis, Peter Wipf